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Jet propulsion fuel-8 (JP-8) is the primary
jet fuel used by the U.S. Air Force and
other members of the North Atlantic Treaty
Organization (NATO), which collectively
consume an estimated 20 billion liters per
year (Zeiger and Smith 1998). Over the last
20 years, JP-8 has completely replaced jet
propulsion fuel-4 (JP-4) in the U.S. Air Force
because of a desire to move toward a single
battlefield fuel and because its higher flash
point and lower vapor pressure make it less
likely to propagate an explosion. JP-8 is a
kerosene-based fuel consisting of approxi-
mately 81% aliphatic hydrocarbons and 19%
aromatic hydrocarbons (Carlton and Smith
2000; White 1999; Zeiger and Smith 1998).
The worldwide annual use of kerosene-based
jet fuels, which includes Jet-A, the commer-
cial airline equivalent of JP-8, is estimated at
around 240 billion liters (Ritchie et al. 2001).
Little is known about exposures to JP-8 or
about possible health effects associated with
exposures. Based upon limited toxicologic data,
it has been speculated that workers exposed to
JP-8 are at increased risk of respiratory, cardio-
vascular, and neurologic effects (ATSDR 1998;
Knave et al. 1976; Porter 1990; Ritchie et al.
2001; Struwe et al. 1983). Because JP-8 is irri-
tating to the skin (Kanikkannan et al. 2001;
McDougal and Robinson 2002) and because
kerosene (the base mixture of hydrocarbons in
JP-8) has caused skin cancer in mice (NTP
1986), dermal contact with this fuel is also
worrisome.
Although exposure to JP-8 can occur at
any stage in the transport or use of jet fuel,
the highest levels are thought to occur during
maintenance of aircraft fuel tanks, where fuel
vapors can accumulate, despite venting before
entry (Carlton and Smith 2000). The risk of
dermal exposure is also great during fuel-tank
maintenance because personnel must first
remove fuel and fire-suppressing foam from
the aircraft and, ultimately, enter the conﬁnes
of the tanks where residual fuel remains. (At
the time this study was conducted, Air Force
fuel-tank workers wore only cotton garments
to prevent static electricity.)
Given the myriad of chemicals comprising
jet fuel, assessing exposures to JP-8 has been
problematic. Several aliphatic and aromatic
hydrocarbons, including C9 to C12 n-alkanes,
benzene, toluene, styrene, and naphthalene,
have been proposed as possible surrogates of
JP-8 exposure, based upon parallel measure-
ments in breathing-zone air and breath
(Carlton and Smith 2000; Egeghy et al. In
press; Pleil et al. 2000; Puhala et al. 1997). Of
these, the aromatic compounds tend to be
more hazardous, with benzene being arguably
the most toxic constituent of jet fuel, because
of its well-recognized hematopoietic and car-
cinogenic effects (IARC 1982; IPCS 1993).
However, although benzene is a minor com-
ponent of JP-8, typically present at much less
than 0.02% (Carlton and Smith 2000; IARC
1989; Irwin et al. 1997), it is abundant in
cigarette smoke and gasoline exhaust (IARC
1989; Rustemeier et al. 2002). Also, because
of the great volatility of benzene (as with
toluene, styrene, and the other of single-ring
aromatic compounds), exposure occurs almost
exclusively via inhalation, with very little der-
mal absorption. For these reasons, benzene is
unlikely to be a good surrogate for JP-8 expo-
sure, even though it is reasonable to assess
exposure to benzene per se among persons
exposed to jet fuel.
Naphthalene is an abundant aromatic
constituent of JP-8 (IARC 1989; White
1999), present at 0.175% in batches of JP-8
from the present study (Egeghy et al. In
press). Unlike benzene, naphthalene is readily
absorbed into the blood via both inhalation
and dermal contact (McDougal and Robinson
2002; NTP 2000) and is only a minor com-
ponent of cigarette smoke and gasoline
exhaust (IARC 1989; Rustemeier et al. 2002).
Thus, naphthalene could be a good surrogate
for JP-8 exposure, and naphthalene-based bio-
markers could be particularly useful in assess-
ing whole-body exposures to jet fuel as the
prelude to studies of health effects.
After exposure, some of the naphthalene
dose is eliminated unchanged in the breath
or urine. However, most of the naphthalene
dose is metabolized via cytochrome P450
enzymes (CYP1A1, CYP1A2, CYP2A1,
CYP2E1, CYP2F1, CYP2F2, CYP3A5, and
CYP3A7) to naphthalene-1,2-epoxide, which
rearranges to 1- and 2-naphthol (Greene et al.
2000; Tingle et al. 1993; Wilson et al. 1996);
these products are excreted in the urine,
either unchanged or after conjugation (NTP
2000). Although recent reports have sug-
gested that the naphthols might be useful bio-
markers of exposure to polycyclic aromatic
hydrocarbons (naphthalene is the simplest
such compound; Bouchard et al. 2001;
Jansen et al. 1995; Yang et al. 1999), here we
consider the potential of naphthols as candi-
dates for biomonitoring of JP-8.
In this study, we measured levels of unme-
tabolized benzene and naphthalene and of
1- and 2-naphthol in the urine of 323 Air
Force personnel. We then compared the levels
of these urinary analytes after a priori catego-
rization of subjects by exposure level (low,
moderate, and high) and by smoking status.
We subsequently investigated the correlations
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Benzene, naphthalene, and 1- and 2-naphthol were measured in urine samples obtained from 322
U.S. Air Force personnel categorized a priori as likely to have low, moderate, or high exposure to
jet fuel [jet propulsion fuel-8 (JP-8)]. In postexposure samples, levels of these analytes in the high-
exposure group were 3- to 29-fold greater than in the low-exposure group and 2- to 12-fold
greater than in the moderate-exposure group. Heavy exposure to JP-8 contributed roughly the
same amount of benzene and more than three times the amount of naphthalene compared with
cigarette smoking. Strong correlations were observed among postexposure levels of naphthalene-
based biomarkers in urine and naphthalene in air and breath. We conclude that urinary naphtha-
lene and the naphthols can serve as biomarkers of exposure to jet fuel. Of these, the naphthols are
probably more useful because of their greater abundance and slower elimination kinetics. Key
words: benzene, biomarkers, exposure assessment, jet fuel, JP-8, naphthalene, naphthols, urine.
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http://dx.doi.org/ [Online 2 July 2003]of the urinary analytes and the corresponding
air and breath levels of benzene and naphtha-
lene in these subjects.
Materials and Methods
Chemicals and supplies. Naphthalene (≥ 99%,
scintillation grade), [2H8]naphthalene (≥ 98
atom% D), 1-naphthol (≥ 99%), 2-naphthol
(≥ 99%), [2H7]1-naphthol (97 atom% D),
[2H6]benzene, and methanol (purge and trap
grade) were obtained from Aldrich Chemical
Co. (Milwaukeee, WI). Benzene was obtained
from Fluka Chemical Co. (St. Gallen,
Switzerland). NaCl was obtained from Fisher
Scientiﬁc (Pittsburgh, PA). β-Glucuronidase/
sulfatase (type H-2 from Helix pomatia; 
β-glucuronidase activity, 105,000 U/mL; sul-
fatase activity, 4,300 U/mL) was obtained
from Sigma Chemical Co. (St. Louis, MO).
Tri-Sil TBT was obtained from Pierce
Chemical (Rockford, IL). Ethyl acetate (ana-
lytical reagent) and hexane (nanograde) were
obtained from Mallinckrodt Baker, Inc.
(Paris, KY).
Study subjects and sampling. Spot urine
samples were collected from 323 active duty
Air Force personnel (on six Air Force bases in
the United States) before and after a 4-hr work
shift (measurements of one subject were
excluded from statistical analyses, as described
below). Urine samples were collected in 15-mL
polyethylene tubes in the ﬁeld and shipped on
dry ice to the laboratory, where they were
stored at –80°C until analysis.
Briefings, press releases, and solicitation
advertisements were used to recruit study vol-
unteers. Subjects were recruited with informed
consent from both sexes (272 males, 51
females) according to their job titles (primary
career ﬁelds) and were categorized into low-,
moderate-, and high-exposure groups based
on the anticipated likelihood of JP-8 exposure
in their jobs. Aircraft fuel-system mainte-
nance workers (jobs: entrant, attendant, run-
ner, and multiple jobs) were assigned to the
high-exposure group. The moderate-exposure
group consisted of workers who did not per-
form fuel tank maintenance but whose work
involved regular contact with jet fuel (jobs: fuel
handling, distribution, etc.). The low-exposure
group consisted of personnel whose job titles
covered a wide variety of activities that did not
require exposure to jet fuel (jobs: military
police, medical technician, and the like).
Information about smoking status was obtained
by questionnaire. Subjects who smoked were
asked to abstain for the duration of the 4-hr
study period. The numbers of subjects catego-
rized by exposure group and smoking status are
summarized in Table 1.
Urinary measurements of one participant
were excluded from all statistical analyses.
Although this person was categorized in the
low-exposure group, he reported being in the
hangar with aircraft fuel maintenance workers
and showed high levels of exposure (benzene,
4.80 µg/m3; naphthalene, 482 µg/m3) com-
pared with the other subjects in the low-expo-
sure group [geometric means (GMs): benzene,
3.25 µg/m3; naphthalene, 2.11 µg/m3].
Analysis of urinary analytes. Urinary ben-
zene, naphthalene, and 1- and 2-naphthol were
measured in all postexposure samples (n = 323)
and in about half of the preexposure samples
(n = 152). Unmetabolized benzene and naph-
thalene were determined in urine via headspace
solid-phase microextraction based upon the
method of Waidyanatha et al. (2001) using a
Varian Model 8200 autosampler (Walnut
Creek, CA) with an Autotherm Peltier con-
troller and carousel (Strumenti Scientific,
Padova, Italy). Brieﬂy, 0.5 mL urine was trans-
ferred to a vial containing 0.5 g NaCl to which
1 µL of a methanol solution of internal stan-
dards, containing 0.5 µg/mL [2H8]naphthalene
and 2.5 µg/mL [2H6]benzene, was added. The
vials were immediately capped and placed in
the carousel at 45°C for 15 min to allow the
analytes to equilibrate. Analytes were concen-
trated from the vial headspace onto a Supelco
(Bellefonte, PA) polydimethylsiloxane fiber
(10-mm × 100-µm ﬁlm thickness) for 15 min
and were then analyzed by gas chromatogra-
phy-mass spectrometry (GC-MS) in selected
ion monitoring (SIM) mode using a Hewlett-
Packard 5980 series II gas chromatograph
coupled to an HP 5971 A mass selective
detector (Hewlett Packard, Palo Alto, CA). A
DB-5 fused silica capillary column was used
(60 m, 0.25-mm inner diameter, 0.25-µm
ﬁlm thickness). Ions at m/z 128 (naphthalene),
136 ([2H8]naphthalene), 78 (benzene), and 84
([2H6]benzene) were monitored. Quantitation
was based on peak area ratios of the analytes
to the internal standards. Preexposure benzene
was not quantiﬁed in one urine sample (low-
exposure group) because of chromatographic
difﬁculties.
Urinary 1- and 2-naphthol levels were
measured as described by Serdar et al. (2003).
Brieﬂy, 2 mL urine was brought to room tem-
perature and 50 µL of a hexane solution con-
taining 1 µg/mL of [2H7]1-naphthol (internal
standard) was added. The sample was
hydrolyzed with 10 µL β-glucuronidase/
sulfatase at 37°C for 17 hr and extracted twice
with a total of 7 mL ethyl acetate. After evapo-
ration under N2, the residue was derivatized
with 10 µL Tri-Sil TBT in 190 µL hexane at
70°C for 30 min. The trimethylsilyl ethers of
the analytes were then analyzed by GC-MS in
SIM mode. Molecular ions at m/z 216
(1- and 2-naphthol), m/z 223 ([2H7]1-naph-
thol) were monitored, and the quantitation
was based on peak area ratios of the naphthols
to [2H7]1-naphthol.
Adjustment for urinary creatinine. Levels
of urinary creatinine in our samples were
provided by another laboratory, which
performed the assays with a Vitros 250
Chemistry System (Ortho-Clinical Diag-
nostics, Rochester, NY). Only urinary naph-
thols were adjusted for creatinine, and all
statistical tests were repeated with and without
adjustment. Because only minor differences
were observed with and without adjustment
for creatinine (summarized in “Results”), only
unadjusted levels of the naphthols are reported
herein. Unmetabolized benzene and naphtha-
lene were not adjusted for creatinine because,
unlike creatinine, which is eliminated through
glomerular filtration and is not reabsorbed,
they are excreted into urine through a concen-
tration-dependent passive process that involves
tubular reabsorption (Boeniger et al. 1993;
Waidyanatha et al. 2001).
Analysis of benzene and naphthalene in air
and breath. Personal exposure to benzene and
naphthalene was monitored during the 4-hr
work shift with passive monitors clipped to the
subject’s clothing in the breathing zone. End-
exhaled air samples were collected from each
subject before and after the work shift using
75-cm3 glass bulbs. Details of the collection
and analysis of benzene and naphthalene in air
and breath samples are presented elsewhere
(Egeghy et al. In press).
Statistical analyses. Multiple comparisons
were applied to test for the differences in mean
(log-transformed) levels of urinary biomarkers
(before and after the exposure) categorized by
work category and cigarette smoking status.
For this purpose, a two-way analysis of vari-
ance (ANOVA) procedure was applied via
Proc GLM of SAS system software (version
8.1; SAS Institute, Cary, NC). GM levels of
urinary analytes in samples collected before
and after exposure were compared using
Student’s t-tests of the logged values (Proc t-
test; SAS). Spearman correlation coefficients
were obtained for pairs of measurements in
urine, air, and breath. All statistical analyses
were performed using SAS at a significance
level (two-tailed) of 0.05. All tests (except
Spearman correlation) were performed after
(natural) logarithmic transformation, and data
were summarized as GMs and geometric stan-
dard deviations (GSDs). A small proportion of
measurements of urinary benzene (n = 1 in a
postexposure sample) and naphthalene (n = 10
in preexposure and n = 15 in postexposure
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Table 1. Distribution of study participants by expo-
sure group (n) and smoking status.
Exposure group (n)
Smoking status, sex Low Moderate High
Nonsmokers
Female 26 3 4
Male 90 17 62
Smokers
Female 12 2 4
Male 38 17 47samples) measurements were below the limit
of detection (LOD); these samples were
assigned a value of LOD/√
– –
2 before statistical
analornung and Reed 1990).
Results
Effects of exposure category and smoking status.
Tables 2 and 3 present summary statistics of
benzene, naphthalene, and 1- and 2-naphthol
in urine samples collected, respectively, before
and after the work shift from subjects classiﬁed
by exposure category and smoking status.
Regarding the preexposure levels, GM levels
of urinary analytes were not different across
exposure groups, except for 1-naphthol, which
was 2-fold higher in the high-exposure group
than in the low-exposure group (p < 0.05).
However, smokers had significantly higher
preexposure levels of all urinary analytes than
nonsmokers except for naphthalene, where sta-
tistical signiﬁcance was approached (p < 0.1)
only in the low- and the high-exposure groups
(Table 2). Regarding postexposure levels
(Table 3), concentrations of all urinary analytes
in the high-exposure group were 3- to 28-fold
higher than those of the low-exposure group
and 2- to 12-fold higher than those of the
moderate-exposure group. Concentrations of
naphthalene and the naphthols were also 2-fold
higher in the moderate-exposure group than
the low-exposure group. Smokers had signi-
ficantly higher levels than nonsmokers of
postexposure samples of all analytes except
naphthalene (Table 3).
When levels of urinary analytes were com-
pared between pre- and postexposure samples
within a given exposure category, postexposure
levels of all analytes were signiﬁcantly greater in
the high-exposure group, but not in the low-
or moderate-exposure groups.
Correlations among measurements in
urine, breath, and air. Spearman correlation
coefficients are shown in Tables 4 and 5 for
preexposure and postexposure samples, respec-
tively, for all urinary analytes as well as for ben-
zene and naphthalene in breathing-zone air and
breath. All coefﬁcients were signiﬁcant except
those involving naphthalene in the breath of
preexposed subjects. Postexposure urinary mea-
surements showed much larger correlation with
measurements in breath (r = 0.366–0.613) and
urine (r = 0.517–0.896) than did those for the
corresponding preexposure samples (r = –0.035
to 0.397 and r = 0.343–0.784, respectively).
The correlation coefﬁcients between levels of
naphthalene and 1- and 2-naphthols dimin-
ished by 30.2 and 38.3%, respectively, in pre-
exposure samples and by 14.7 and 11.9%,
respectively, in postexposure samples when
naphthols were adjusted for urinary creatinine
(data not shown).
Discussion
JP-8 exposure is believed to be the most com-
mon chemical exposure experienced by Air
Force personnel, and similar exposures are
expected among workers at commercial air-
lines from Jet-A. Despite the common expo-
sures worldwide and speculation that JP-8
might be associated with adverse health effects
(ATSDR 1998; Ritchie et al. 2001), very few
investigations have monitored exposures to
constituents of jet fuel. In the present study,
we investigated levels of benzene, naphthalene,
and 1- and 2-naphthol in the urine of smok-
ing and nonsmoking workers expected to have
low, moderate, and high exposure to JP-8.
Our primary aim was to determine whether
naphthalene and its biomarkers might be use-
ful surrogates for JP-8 in studies of health
effects associated with exposure to jet fuel. We
observed much lower levels of naphthalene in
urine than those of the naphthols, which is not
surprising because relatively small amounts
(< 1–2%) of unmetabolized aromatic com-
pounds are eliminated in urine (Ghittori et al.
1993; Parke 1996; Turkall et al. 1994). When
we aggregated postexposure levels of urinary
naphthalene and 1- and 2-naphthol by expo-
sure category, the values supported the a priori
categorization based upon job title (Table 3).
Levels of naphthalene, and 1- and 2-naphthol
were approximately 28-, 13-, and 10-fold
higher, respectively, in postexposure urine sam-
ples in the highest category compared with the
lowest category. This suggests that the urinary
biomarkers of naphthalene did indeed track
the extent to which subjects in the selected jobs
were thought to have contact with JP-8.
In the present study, postexposure levels of
urinary 1- and 2-naphthols in the low-exposed
group were comparable with previously
reported mean values in control populations, as
summarized in Table 6. Levels of postexposure
urinary 1- and 2-naphthol in workers with
heavy JP-8 exposures (19.8 and 28.1 µg/L,
Environmental Medicine | Serdar et al.
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Table 4. Correlation among biomarkers in urine (µg/L) and breath (µg/m3) in preexposure samples of all
subjects [Spearman coefﬁcients (p-value)].
Benzene (urine) Naphthalene (urine) 1-Naphthol (urine) 2-Naphthol (urine)
Benzene (breath) 0.397 (< 0.0001) 0.202 (0.013) 0.345 (< 0.0001) 0.356 (< 0.0001)
Naphthalene (breath) –0.084 (0.313) 0.135 (0.100) –0.035 (0.671) –0.072 (0.385)
Benzene (urine) 0.343 (< 0.0001) 0.550 (< 0.0001) 0.607 (< 0.0001)
Naphthalene (urine) 0.482 (< 0.0001) 0.397 (< 0.0001)
1-Naphthol (urine) 0.784 (< 0.0001)
Table 5. Correlation among exposure measurements (air; µg/m3) and biomarkers in urine (µg/L) and breath
(µg/m3) in postexposure samples of all subjects [Spearman coefﬁcients (p-value)].
Benzene (urine) Naphthalene (urine) 1-Naphthol (urine) 2-Naphthol (urine)
Benzene (breath) 0.589 (< 0.0001) 0.455 (< 0.0001) 0.613 (< 0.0001) 0.575 (< 0.0001)
Naphthalene (breath) 0.366 (< 0.0001) 0.478 (< 0.0001) 0.552 (< 0.0001) 0.508 (< 0.0001)
Benzene (air) 0.476 (< 0.0001) 0.659 (< 0.0001) 0.721 (< 0.0001) 0.689 (< 0.0001)
Naphthalene (air) 0.461 (< 0.0001) 0.692 (< 0.0001) 0.720 (< 0.0001) 0.694 (< 0.0001)
Benzene (urine) 0.517 (< 0.0001) 0.643 (< 0.0001) 0.645 (< 0.0001)
Naphthalene (urine) 0.690 (< 0.0001) 0.648 (< 0.0001)
1-Naphthol (urine) 0.896 (< 0.0001)
Table 2. Preshift urinary measurements among controls and U.S. Air Force personnel exposed to JP-8.
Low Moderate High
Urinary analyte NS (n = 48) S (n = 26) NS (n = 8) S (n = 8) NS (n = 36) S (n = 26)
Benzene 0.554a (1.55) 2.10* (3.32) 0.568 (1.83) 3.13*(3.33) 0.709 (1.90) 1.72*(2.58)
Naphthalene 0.014 (4.79) 0.027#(2.46) 0.025 (3.20) 0.032 (1.68) 0.016 (6.51) 0.033#(2.80)
1-Naphthol 1.19 (3.16) 3.98* (2.63) 1.85 (2.36) 5.52** (1.61) 2.04 (3.24) 7.76*(3.10)
2-Naphthol 2.06 (2.75) 7.55* (2.60) 2.10 (2.10) 7.77** (1.52) 2.06 (2.27) 9.49* (2.54)
Abbreviations: NS, nonsmokers; S, smokers. GMs (µg/L) and GSDs (in parentheses) are shown by exposure category and
smoking status.
an = 47. *p < 0.0001; **p < 0.05; #p < 0.1 for test of equal GMs against the nonsmokers within the exposure category (two-
way ANOVA of log-transformed data).
Table 3. Postshift urinary measurements among controls and U.S. Air Force personnel exposed to JP-8.
Low Moderate High
Urinary analyte NS (n = 116) S (n = 50) NS (n = 20) S (n = 19) NS (n = 66) S (n = 51)
Benzene 0.695 (1.64) 1.60* (2.60) 0.675 (1.52) 2.56*(2.78) 1.81 (2.80) 3.71*(3.40)
Naphthalene 0.014 (4.08) 0.012 (4.71) 0.025 (2.68) 0.040 (2.09) 0.316 (11.2) 0.457 (4.93)
1-Naphthol 0.945 (2.59) 4.24* (2.79) 1.57 (2.87) 6.44* (2.35) 15.9 (3.21) 26.3** (2.32)
2-Naphthol 1.77 (2.72) 7.20* (3.21) 3.78 (2.81) 10.7** (2.54) 22.6 (3.46) 37.3** (2.48)
Abbreviations: NS, nonsmokers; S, smokers. GMs (µg/L) and GSDs (in parentheses) are shown by exposure category and
smoking status.
*p < 0.0001, **p < 0.05 for test of equal GMs against the nonsmokers within the exposure category (two-way ANOVA of
logged data).respectively) were lower than levels observed in
workers positioned at tops of coke ovens (58.5
and 34.1 µg/L, respectively; Serdar et al. 2003)
but were comparable with those observed in
working at the bottoms or sides of the same
coke ovens (30.0 and 26.9 µg/L).
Because preexposure urine samples showed
very little evidence of a trend from low to high
JP-8 exposure (Table 2), we conclude that the
urinary biomarkers of naphthalene are very
short-lived. Previous studies suggested two-
phase excretion kinetics for the naphthols in
urine, consisting of a rapid phase with half-lives
(t1/2) of 1.2–4.6 hr, followed by a slower phase
with 14 ≤ t1/2 ≤ 46 hr (Bieniek 1994; Heikkilä
et al. 1995). Our results suggest that most of
the naphthols were eliminated during the rapid
phase. Although the elimination kinetics of
unmetabolized naphthalene have not been
reported in urine, they probably track those of
naphthalene in breath, which had an estimated
t1/2 of 22 min in our subjects (Egeghy et al. In
press). Given such rapid removal, very little
naphthalene would be expected on the day after
exposure, consistent with our results.
In each exposure category, smokers had
higher levels of urinary benzene, naphthalene,
and the naphthols in both pre- and post-
exposure samples. Because cigarette smoking
is reportedly the greatest source of benzene
among the general public (Ashley et al. 1996;
Darrall et al. 1998), it is not surprising that
smokers would have higher levels of urinary
benzene than would nonsmokers. Among
heavily exposed workers who did not smoke,
levels of postexposure urinary benzene (GM =
1.81 µg/L) were about the same as values
observed in low-exposed smokers (essentially
control subjects; GM = 1.60 µg/L). This sug-
gests that the contribution of benzene arising
from JP-8 exposure in the heavily exposed
subjects was roughly equal to that from ciga-
rette smoking.
The postexposure levels of urinary benzene
observed among our low-exposed subjects were
somewhat higher than those reported among
controls in other investigations (Table 6). On
the other hand, postexposure measurements of
urinary benzene from the high-exposure group
(GM = 1.81 µg/L for nonsmokers, 3.71 µg/L
for smokers) were comparable with those of
workers in a shoe manufacturing plant (GM =
4.8 µg/L; Ong et al. 1995) and of workers in
chemical plants and at gasoline pumps (GM =
1.26 µg/L for nonsmokers, 2.6 µg/L for smok-
ers; Ghittori et al. 1993), but were much lower
than the levels observed in workers heavily
exposed to benzene as a solvent (GM =
50.2 µg/L; Waidyanatha et al. 2001).
Naphthalene is also present in cigarette
smoke, albeit at lower concentrations than
benzene (in mainstream smoke: naphthalene,
0.276 µg/cigarette; benzene, 39.8 µg/cigarette;
Rustemeier et al. 2002). Thus, we anticipated
that smokers would have somewhat higher
levels of urinary naphthalene and the naph-
thols than nonsmokers. This was observed in
all exposure categories (Table 3), consistent
with previous results among Chinese coke
oven workers and controls (Serdar et al. 2003;
Waidyanatha et al. 2003). However, the effect
of smoking upon naphthol levels was much
less prominent than that of JP-8 exposure in
our study; indeed, among heavily exposed sub-
jects, the naphthols were not significantly
greater in smokers than in nonsmokers but
were about 10-fold greater than the corre-
sponding levels in the low-exposure category
(Table 3). Levels of urinary 1- and 2-naphthols
in nonsmokers of the heavily exposed group
(15.9 and 22.6 µg/L, respectively) were signif-
icantly higher than those of smokers in the
low-exposure group (4.24 and 7.20 µg/L,
respectively), suggesting that naphthalene expo-
sure arising from JP-8 was more than three
times higher than that from cigarette smoke.
If the exposures to surrogate compounds
such as benzene and naphthalene originated
from JP-8 among study subjects, it is reasonable
to expect strong correlations among those
surrogates in various biologic media, provided
that the sampling times were sufﬁcient for each
analyte. We examined the relationships
between levels of benzene and naphthalene in
air, breath, and urine. Although signiﬁcant cor-
relation was generally observed between the
naphthalene and benzene biomarkers in both
pre- and postexposure samples, correlation coef-
ﬁcients observed for samples obtained after the
work shift tended to be much larger (Tables 4
and 5). This supports the presumption that
there was a common source of exposure to ben-
zene and naphthalene during the work shift.
We conclude that JP-8 is a significant
source of exposure to benzene and naphtha-
lene. Among heavily exposed workers, JP-8
contributes about the same benzene dose as
cigarette smoking and more than three times
the naphthalene dose as cigarette smoking.
Our results indicate that unmetabolized naph-
thalene, as well as 1- and 2-naphthol, could
serve as possible short-term biomarkers of JP-8
exposure. Of these, the naphthols are probably
more useful because of their greater abundance
and slower elimination kinetics.
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